Travere Therapeutics Inc Free Cash Flow Generation Index

Latest as of June 2026: 1.00x

Travere Therapeutics Inc free cash flow generation index. Travere Therapeutics Inc (TVTX) has a Free Cash Flow Generation Index of 1.00x as of June 2026. Free cash flow of $58.07 Million represents 1% of operating cash flow ($58.07 Million).

FCF Generation Index

1.00x
Free Cash Flow / Operating CF

Free Cash Flow

$58.07 Million
USD

Operating Cash Flow

$58.07 Million
USD

Capital Expenditures

$22.18 Million
USD

Free Cash Flow Generation Index of Travere Therapeutics Inc (2017–2025)

Free cash flow generation index of Travere Therapeutics Inc from 2017 to 2025. Historical FCF Generation Index trend for Travere Therapeutics Inc across 2 annual periods. See TVTX financial flexibility score to measure the company's free cash flow as a share of total liabilities.

Travere Therapeutics Inc Free Cash Flow Generation Index by Year (2017–2025)

Travere Therapeutics Inc free cash flow generation index by year from 2017 to 2025. Year-by-year Free Cash Flow Generation Index for Travere Therapeutics Inc. For the full cash flow conversion analysis, see Travere Therapeutics Inc cash flow conversion.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2025 -0.54x $-20.37 Million $37.78 Million $58.16 Million ▲ +39.6%
2017 -0.89x $-6.61 Million $7.40 Million $14.01 Million —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).